Literature DB >> 19099243

Isolation and application of bioactive Wnt proteins.

Karl H Willert1.   

Abstract

Wnt proteins and their signaling cascades are involved in a wide variety of developmental processes, and deregulation of this pathway is frequently associated with tumorigenesis. Unlike many other growth factors, Wnts long eluded biochemical purification, in large part because of their hydrophobic nature, which is imparted by one or more lipid modifications. Here I describe a complete protocol that outlines the purification process for Wnt proteins. While this protocol has not been applied to all known Wnt proteins, it has been successfully applied to the purification of a large subset of Wnts, including the very divergent Wnt protein, Drosophila Wnt8 (Dwnt8 or WntD), indicating that this protocol is likely applicable to all Wnts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19099243     DOI: 10.1007/978-1-59745-249-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

1.  Arrayed cellular microenvironments for identifying culture and differentiation conditions for stem, primary and rare cell populations.

Authors:  David A Brafman; Shu Chien; Karl Willert
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

2.  Isolation and characterization of recombinant murine Wnt3a.

Authors:  Andrzej Witkowski; Aparna Krishnamoorthy; Betty Su; Jennifer A Beckstead; Robert O Ryan
Journal:  Protein Expr Purif       Date:  2014-11-08       Impact factor: 1.650

3.  Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs.

Authors:  Jacomijn P Dijksterhuis; Bolormaa Baljinnyam; Karen Stanger; Hakki O Sercan; Yun Ji; Osler Andres; Jeffrey S Rubin; Rami N Hannoush; Gunnar Schulte
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

4.  The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells.

Authors:  Antonio Fernandez; Ian J Huggins; Luca Perna; David Brafman; Desheng Lu; Shiyin Yao; Terry Gaasterland; Dennis A Carson; Karl Willert
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

5.  Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Authors:  Nicolas Aznar; Krishna K Midde; Ying Dunkel; Inmaculada Lopez-Sanchez; Yelena Pavlova; Arthur Marivin; Jorge Barbazán; Fiona Murray; Ulrich Nitsche; Klaus-Peter Janssen; Karl Willert; Ajay Goel; Miguel Abal; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

6.  A rare human syndrome provides genetic evidence that WNT signaling is required for reprogramming of fibroblasts to induced pluripotent stem cells.

Authors:  Jason Ross; Julia Busch; Ellen Mintz; Damian Ng; Alexandra Stanley; David Brafman; V Reid Sutton; Ignatia Van den Veyver; Karl Willert
Journal:  Cell Rep       Date:  2014-11-20       Impact factor: 9.423

Review 7.  WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3.

Authors:  J P Dijksterhuis; J Petersen; G Schulte
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 8.  Wnt signaling in myogenesis.

Authors:  Julia von Maltzahn; Natasha C Chang; C Florian Bentzinger; Michael A Rudnicki
Journal:  Trends Cell Biol       Date:  2012-08-31       Impact factor: 20.808

9.  A study on the interactions between heparan sulfate proteoglycans and Wnt proteins.

Authors:  Christophe Fuerer; Shukry J Habib; Roel Nusse
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

10.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.